The evolving public perception of obesity stigma reflects a gradual shift toward recognizing obesity as a complex medical condition influenced by biological and environmental factors, rather than a simple matter of personal responsibility
A small exploratory study in 2005 did just that
Evidence Summary Current evidence supports the following conclusions: GLP-1 drugs reduce caloric intake Reduced intake may reduce micronutrient consumption Delayed gastric emptying does not equal malabsorption Rapid weight loss may increase lean mass vulnerability Long-term micronutrient outcome data remain limited There is mechanistic plausibility for nutritional risk in certain populations, but no strong evidence of universal depletion across all patients
But follow your provider's guidance on titration speed
They also have lower glutathione levels
Thats telling us that there is likely a common biologic pathway that is driving all of these addictions that is indeed druggable or treatable by GLP-1. The proteins on brain cells that receive chemical signals from GLP-1 drugs, known as GLP-1 receptors, are found in an area called the mesolimbic system that is responsible for motivation and reward signaling, Al-Aly noted